Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / January / Protecting the Neuron
Neuro-ophthalmology Glaucoma Opinions

Protecting the Neuron

Could neuroprotective therapies offer new hope for glaucoma and a host of other eye conditions?

By Alun Evans 1/7/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Top Institutions in Neuroprotection in Ophthalmology

Leading academic medical centers with strong ophthalmology and neuroscience research programs are pioneering translational research in neuroprotection, combining molecular pathway elucidation, animal model experimentation, and early drug development to advance potential therapies for glaucoma and related neurodegenerative eye diseases.

  • #1

    University of California, San Francisco (UCSF)

    San Francisco, CA

    UCSF is a leader in ophthalmic neuroprotection research, with faculty like Dr. Eugene de Juan, Jr. spearheading translational efforts to develop novel neuroprotective drugs targeting glaucoma, supported by strong clinical and pharmaceutical collaborations.

    Key Differentiators

    • Ophthalmology
    • Neuroprotection
    • Retinal Research
  • #2

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins is renowned for its pioneering research in ocular neurodegeneration and regenerative medicine, with leaders like Dr. Donald Zack advancing understanding of molecular pathways such as DLK/LZK and stem cell approaches to ocular neuroprotection.

    Key Differentiators

    • Ophthalmology
    • Neuroscience
    • Stem Cell Research
  • #3

    Stanford University

    Stanford, CA

    Stanford has made significant breakthroughs in neuroprotective strategies for neurodegenerative diseases including Parkinson’s and Alzheimer’s, providing foundational insights that inform glaucoma neuroprotection research.

    Key Differentiators

    • Neuroscience
    • Ophthalmology
    • Neurodegenerative Disease Research
  • #4

    University of Michigan

    Ann Arbor, MI

    The University of Michigan has a strong ophthalmology department with active research in neuroprotective therapies for glaucoma and retinal diseases, contributing to preclinical and clinical studies.

    Key Differentiators

    • Ophthalmology
    • Neuroprotection
    • Vision Science

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: